Saliba, Rima M.
~ 1000  results:
Search for persons X
?
 
?
 
?
6

HLA Factors versus Non-HLA Factors for Haploidentical Donor..:

Mehta, Rohtesh S. ; Cao, Kai ; Saliba, Rima M....
Transplantation and Cellular Therapy.  29 (2023)  3 - p. 189-198 , 2023
 
?
7

Myeloablative Fractionated Busulfan Regimens in Matched Don..:

Popat, Uday R. ; Saliba, Rima M. ; Mehta, Rohtesh S....
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S164-S165 , 2023
 
?
8

Long-Term Follow-up Outcomes of Patients That Underwent All..:

Marinos, Alejandro ; Ramdial, Jeremy L ; Saliba, Rima M....
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S339-S340 , 2023
 
?
9

Myeloablative Fractionated Busulfan Fludarabine and Thiotep..:

Popat, Uday R. ; Saliba, Rima M. ; Mehta, Rohtesh S....
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S167 , 2023
 
?
12

Impact of Gender on Outcomes of Patients with Multiple Myel..:

Pasvolsky, Oren ; Saliba, Rima M. ; Masood, Adeel...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S404-S405 , 2023
 
?
13

Mycophenolate Mofetil: A Friend or a Foe with Post-Transpla..:

Mehta, Rohtesh S. ; Saliba, Rima M. ; Hayase, Eiko...
Transplantation and Cellular Therapy.  28 (2022)  8 - p. 500.e1-500.e10 , 2022
 
?
14

Haploidentical versus Matched Unrelated versus Matched Sibl..:

Mehta, Rohtesh S. ; Saliba, Rima M. ; Ghanem, Sassine...
Transplantation and Cellular Therapy.  28 (2022)  7 - p. 395.e1-395.e11 , 2022
 
?
15

Characteristics of Graft-Versus-Host Disease (GvHD) After P..:

Saliba, Rima M. ; Alousi, Amin M. ; Pidala, Joseph...
Transplantation and Cellular Therapy.  28 (2022)  10 - p. 681-693 , 2022
 
1-15